February 9, 2011

Women with ovarian cancer who received a drug made by Genentech lived longer without their disease becoming worse, according to a late-stage clinical trial.

February 7, 2011

The Food and Drug Administration has approved a generic cancer drug from Hospira.

December 9, 2010

An investigational treatment for lung cancer made by Boehringer Ingelheim Pharmaceuticals extended patients’ survival by more than four months, according to results of a late-stage clinical trial announced Thursday.

September 14, 2010

A new study released Wednesday by the American Lung Association, and conducted by researchers at...

June 15, 2010

Drug maker OXiGENE has finished enrolling patients for a mid-stage clinical trial of a lung...

June 13, 2010

A drug made by Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals failed to extend overall survival...

May 20, 2010

Data from a late-stage clinical trial of an investigational drug by Boehringer Ingelheim could show...

May 19, 2010

A retailer in the United Kingdom said Thursday it would become the first to sell...

March 11, 2010

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 11, 2010

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

January 18, 2010

The Food and Drug Administration has extended its review period for a lung cancer drug...

January 12, 2010

Researchers in Arizona have found a way to predict which patients might be resistant to...

November 22, 2009

For all the good that associations like the Council for Responsible Nutrition and the Natural...